Updates in Functional Movement Disorders: from Pathophysiology to Treatment Advances.
Curr Neurol Neurosci Rep
; 22(5): 305-311, 2022 05.
Article
in English
| MEDLINE | ID: covidwho-1800311
ABSTRACT
PURPOSE OF REVIEW This review discusses advances in functional movement disorders (FMD) over the past 3 years, with a focus on risk factors, diagnosis, pathophysiology, neuroimaging studies, and treatment. RECENT FINDINGS:
The past decade has brought a revived interest in functional movement disorders, with a growing number of studies exploring pathophysiological mechanisms. Here, we review recent studies demonstrating changes in attention, emotional and sensorimotor function in FMD. Through international collaborative efforts, progress has been made in defining biomarkers and outcome measures, an important prerequisite towards standardization of diagnosis and reporting of outcomes in clinical trials. Of particular interest are neuroimaging studies demonstrating functional and structural changes in motor and emotional brain circuits, deepening our understanding of FMD as a neurocircuit disorder and potentially paving the way towards new treatments. Currently available treatment modalities have shown successful outcomes via outpatient, inpatient, and virtual delivery. The last 3 years have seen tremendous efforts to better understand, diagnose, and treat FMD. The disease model has been broadened to include a biopsychosocial formulation, and insights on the pathophysiology on FMD are informing treatment efforts. Several international multidisciplinary research collaborations are underway to define biomarkers and best outcome measures, highlighting the path towards improved standardization of future treatment trials. Additionally, the rise of telemedicine during the COVID-19 pandemic has reduced geographic barriers and paved the way for virtual therapy sessions and self-guided programs.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Conversion Disorder
/
COVID-19
/
Movement Disorders
Type of study:
Diagnostic study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Curr Neurol Neurosci Rep
Journal subject:
Neurology
Year:
2022
Document Type:
Article
Affiliation country:
S11910-022-01192-9
Similar
MEDLINE
...
LILACS
LIS